Literature DB >> 28073597

En-bloc resection of the pelvis (EnBRP) in patients with stage IIIC-IV ovarian cancer: A 10 steps standardised technique. Surgical and survival outcomes of primary vs. interval surgery.

Roberto Tozzi1, Kieran Hardern2, Kumar Gubbala2, Riccardo Garruto Campanile2, Hooman Soleymani Majd2.   

Abstract

OBJECTIVE: In this study we describe the technique of the En-bloc resection of the pelvis (EnBRP) in 10 standardised and reproducible steps, whereby all pelvic organs, except the bladder, are removed together with the peritoneum. In addition, we compare the surgical and survival outcomes of patients who underwent upfront vs. interval surgery.
METHODS: Retrospective analysis of patients with FIGO Stage IIIC-IV ovarian cancer treated with Visceral Peritoneal Debulking (VPD) who had EnBRP. The study population was divided into Group 1 (up-front VPD) and group 2 (VPD after neo-adjuvant chemotherapy). The aim was to assess the incidence of EnBRP. We also assessed rate of complete resection (CR), procedure-specific and overall morbidity, disease free and overall survival. Results were compared between group 1 and 2.
RESULTS: Overall 92 out of 200 patients (46%) needed an EnBRP during the VPD. Forty-eight patients were in Group 1 and 44 patients in Group 2. CR was achieved in all patients. No intra-operative procedure specific morbidity was recorded. Dehiscence of bowel anastomosis was the only procedure specific morbidity. Rate was 2%, with 1 episode recorded in each group. Both patients were managed and settled with formation of a bowel diversion. The overall morbidity rate was 33%, 35% in group 1 and 31% in group 2. The mortality rate was 1%. Median disease free survival was 20months, 25 in group 1 vs. 15 in group 2 (P=0.009).
CONCLUSIONS: EnBRP is a safe and effective technique to tackle the pelvic disease of patients with advanced ovarian cancer. The reduced blood loss, the high rate of clear margins and CR of the disease are accompanied by a low rate of surgical morbidity. These features are particularly suitable for patients who are due to start or re-start chemotherapy. The standardization of the technique will make it more reproducible and easier to be taught. In addition, it will facilitate comparison of results and the inclusion of this technique in the portfolio of procedures as part of debulking surgery. Copyright Â
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complete resection; Cytoreduction; En-bloc resection; Ovarian cancer

Mesh:

Year:  2017        PMID: 28073597     DOI: 10.1016/j.ygyno.2016.12.019

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

2.  Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Jvan Casarin; Ahmet Baysal; Gaetano Valenti; Yakup Kilic; Hooman Soleymani Majd; Matteo Morotti
Journal:  J Gynecol Oncol       Date:  2018-11-30       Impact factor: 4.401

3.  Rectosigmoid resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: morbidity of gynecologic oncology vs. colorectal team.

Authors:  Roberto Tozzi; Gaetano Valenti; Daniele Vinti; Riccardo Garruto Campanile; Massimo Cristaldi; Federico Ferrari
Journal:  J Gynecol Oncol       Date:  2021-05       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.